




Another Name乐伐替尼,仑伐替尼,乐卫玛,Lenvima,E7080
IndicationsLenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma (EC).
Reg No.03 L 1079/24
Inspection No.0557-24
WhatsApp: